GLP-1 (Ozempic, Mounjaro) and Facial Harmonization Planning

In recent years, GLP-1 agonists and the analogs that act on more than one receptor, known by names such as Ozempic and Mounjaro, have entered the routine of many aesthetic patients. They arrive at the office with a face that is changing quickly: less full cheeks, deeper folds, skin that seems to be in excess. The instinctive reaction is to fill. The careful reaction is to ask first: where is this face heading?

This text is about planning, not prescribing or technique. The decision about the medication belongs to the physician who prescribed it, and the harmonization professional works with what the face presents. For the general reasoning on volume loss, see facial volume loss after weight loss and Ozempic face: facial assessment.

What changes in the face of someone who loses weight quickly?

Weight loss reduces fat throughout the body, including the face. The superficial and deep fat compartments shrink, and that alters support and shadows. Some common findings:

• Midface. Loss of cheekbone volume and of the cheek fat pad, with deepening of the nasolabial fold and the infraorbital area. See deep medial cheek fat.
• Temples and orbit. A more hollowed look, with deeper under-eye hollows.
• Lower third. Loss of definition, with formation of jowls and marionette lines.
• Skin. With less support, the skin may become laxer, especially in older people, with photodamage, or with very rapid weight loss.

The magnitude varies: age, genetics, fat profile, and speed of loss change the picture. Not every patient on GLP-1 develops visible facial changes, and not every change is due to the medication.

Why wait for weight to stabilize?

The main planning error is treating a moving face as if it were static. Adding volume while weight is still dropping can lead to:

1. Relative excess of volume when the loss continues, with the filler becoming proportionally larger in a thinner face.
2. Loss of naturalness, because the volume placed does not follow the change in the surrounding tissues.
3. The need for multiple touch-ups, with accumulated cost, swelling, and risk.
4. Overcorrection when weight returns. If the patient stops the medication and regains weight, the filler added to the fat gain can produce a face that is too full. See pillow face: overfilled face and overcorrected cheekbone.

On the other hand, waiting also has an emotional cost: the patient wants it fixed now. The alternative is to design a phased plan, with what is prudent to do while weight has not stabilized.

Which approaches usually go into the plan?

Without getting into technique, a few principles guide the reasoning:

• Reversibility when possible. Hyaluronic acid allows adjustment and reversal with hyaluronidase, which is useful while the face is still changing. Hyaluronidase must be available.
• Collagen stimulation with biostimulators can be considered to improve skin quality and support, with the caveat that the effect is gradual and variable. See biostimulator and skin quality.
• Skin quality with skin boosters, microneedling, and other methods, which do not depend on volume.
• Moderation. Small amounts, assessing the response and returning, tend to be safer than one large correction.
• Attention to layers. Loss of deep fat, laxity, and bone loss add up. See facial aging by layers and facial bone resorption with age.
• Recognizing the limit. Significant excess skin may call for surgical assessment; referring is part of the care.

What to ask in the medical history?

Beyond the usual history, it is worth understanding the context of the medication and the weight. You do not prescribe or stop the GLP-1, but you can record the information that influences the plan.

If there are signs of dehydration, significant malaise, or complaints suggesting a medical problem, the guidance is to postpone the procedure and refer to the responsible physician. The medical history in facial harmonization should record all of this.

How to talk with the patient?

The subject mixes aesthetics, health, and, often, self-esteem. The patient may be happy with their body and unhappy with their face, or the opposite. Listen before explaining, and avoid comments about weight that sound like judgment. The conversation guide is in how to talk about weight and face in the consultation.

Align expectations: facial treatment does not return exactly the face from before, and the face after weight loss may be different from the one desired. There are situations in which the best guidance is to monitor and wait.

What about follow-up?

Follow-up is part of the plan, not an extra. Standardized photos at regular intervals, with the same light and distance, show the trend of the face regardless of memory. See standardized clinical photography. Record the reported weight, the photos, and the decisions in the patient record.

And in Harmy?

Summary

In someone on or off GLP-1, the face is a moving target. The safest planning waits for stabilization when possible, prioritizes skin quality and reversibility, adds volume moderately, follows up with photos, and recognizes when to refer. Listening to the patient and aligning expectations about what facial treatment can and cannot do avoids frustration on both sides.